Vaccine production in Bangladesh: Experts vehemently against private sector’s engagement
UNB
17th May, 2021 04:11:56
Though local pharmaceutical companies are showing a growing interest in either procuring or manufacturing Covid vaccines, local health experts say it is the government not the private sector that should collect or produce jabs for ensuring their quality, affordability and accessibility.
They also voiced doubt about the capabilities of the three companies that proposed the government to manufacture Russia s Sputnik V vaccine in Bangladesh.
The analysts suggested the government assess whether the Institute of Public Health (IPH) or state-owned Essential Drugs Company Limited (EDCL) can be modernised within a short period of time to manufacture Covid vaccines.
Covid vaccine stock running out: DGHS
Sun Online Desk
5th May, 2021 05:49:17
The Directorate General of Health Services (DGHS) on Wednesday said the stock of the Covid-19 vaccine is running out in Bangladesh as there are only 14 lakh jabs in government hands with no sign in sight to get a fresh consignment of it from India.
Speaking at a virtual press briefing, DGHS spokesperson Dr Robed Amin said, “We had around one crore and two lakh vaccines in our hands…around 88 lakh jabs have already been administered as the first and second doses. Now we’ve some 14 lakh doses in stock.”
Renata seeks permission to bring Moderna’s Covid-19 vaccine
FILE PHOTO: Walmart pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine inside a Walmart department store as Walmart and other major US pharmacies take part in the Federal Retail Pharmacy Program, to increase vaccinations in the US in West Haven, Connecticut, US, February 17, 2021. REUTERS/Mike Segar Star Digital Report Star Digital Report
Bangladeshi pharmaceutical company Renata Limited has sought permission from the government to bring Moderna s Covid-19 vaccine to the country.
Dr Abul Bashar Mohammad Khurshid Alam, director general of the Directorate General of Health Services, shared the information during a programme in Dhaka today.
Serum Institute of India has been in talks with Beximco about producing the Oxford-AstraZeneca vaccine in Bangladesh.
Serum s discussion with its Bangladeshi agent Beximco Pharmaceuticals Ltd is part of an effort to ramp up production as the former struggles to meet the demand in India and the global supply commitments.
Beximco has asked Serum about the amount of doses that can be produced here and where the doses would be supplied to, Beximco Managing Director Nazmul Hassan Papon said. Local production requires a large investment. Before making the investment, we need to study its feasibility. It won t be viable if we produce only for the local market. We are waiting for a formal proposal [from Serum], Papon told The Daily Star yesterday.
Deal signed for local production of Russian vaccine newagebd.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newagebd.net Daily Mail and Mail on Sunday newspapers.